Bilirubin Meters Market (2025): Growth Drivers, Investment Opportunities

Market Size and Growth

Bilirubin Meters Market reached US$ 119.08 million in 2024 and is expected to reach US$ 304.81 million by 2033, growing at a CAGR of 11.1% during the forecast period 2025-2033.

United States: Recent Industry Developments
✅ February 2026: Leading medical device manufacturers introduced next-generation non-invasive bilirubin meters with improved accuracy for neonatal screening.
✅ January 2026: Hospitals expanded adoption of portable bilirubin testing devices to enhance point-of-care diagnostics in maternity wards.
✅ December 2025: Regulatory authorities updated clinical guidelines to support standardized bilirubin monitoring for newborn jaundice management.

Download Free Sample PDF Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/bilirubin-meters-market?kb

Japan: Recent Industry Developments
✅ February 2026: Japanese medtech firms launched compact transcutaneous bilirubin meters integrated with digital health record systems.
✅ January 2026: Research collaborations focused on AI-enabled bilirubin measurement technologies to improve early detection of neonatal hyperbilirubinemia.
✅ December 2025: Government-supported healthcare programs promoted the use of advanced bilirubin meters in regional hospitals and clinics.

Major Top Key Players:

Delta Medical International Ltd, Mennen Medical Ltd, Ningbo David Medical Device Co. Ltd., Micro Lab Instruments, Zeal Medical, Drägerwerk AG & Co. KGaA, Labtron Equipment Ltd, Korrida Medical Systems, and GPC Medical Ltd

Growth Forecast Projection:

The Global Bilirubin Meters Market is anticipated to rise at a considerable rate during the forecast period, between 2026 and 2033. In 2025, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Key Developments:

✅ February 2026 - United States: Hospitals and neonatal care centers accelerated adoption of advanced transcutaneous bilirubin meters to support early detection of neonatal jaundice and reduce the need for invasive blood sampling procedures.

✅ January 2026 - United States: Medical device manufacturers expanded production capacity for portable and non-invasive bilirubin monitoring systems, integrating improved sensor accuracy and digital data connectivity features.

✅ December 2025 - Japan: Healthcare providers increased implementation of compact bilirubin meters in maternity wards to enhance newborn screening efficiency and support early discharge protocols.

✅ November 2025 - Germany: Hospitals strengthened neonatal diagnostic infrastructure by adopting next-generation bilirubin meters with enhanced calibration systems and electronic health record (EHR) integration capabilities.

✅ October 2025 - China: Domestic manufacturers scaled up automated production of cost-effective bilirubin monitoring devices to meet rising birth rates in urban hospitals and expanding pediatric care facilities.

✅ August 2025 - United Kingdom: National healthcare institutions invested in non-invasive bilirubin measurement technologies to improve neonatal care quality and reduce laboratory workload.

✅ June 2025 - India: Growing awareness of neonatal jaundice management and expansion of maternal healthcare programs encouraged increased procurement of portable bilirubin meters across public and private hospitals.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=bilirubin-meters-market?kb

Regional Analysis for Market:

• United States: 18% - Strong demand driven by advanced neonatal care infrastructure and high hospital adoption of non-invasive bilirubin meters.

• Japan: 8% - Supported by technological innovation in neonatal monitoring and strong healthcare system integration.

• Europe: 22% - Growing market fueled by increasing newborn screening programs and regulatory support for early jaundice detection.

• United Kingdom: 6% - Steady adoption in NHS hospitals emphasizing early diagnosis and reduced invasive testing.

• South Korea: 7% - Rising demand due to expanding maternity care facilities and advanced medical device adoption.

• Middle East & Africa: 9% - Emerging growth supported by improving neonatal care infrastructure and government healthcare investments.

• Germany: 10% - Leading European contributor with strong hospital infrastructure and focus on newborn health monitoring.

• Canada: 5% - Consistent growth driven by high-quality maternal and infant healthcare services.

• Asia-Pacific: 15% - Significant share backed by high birth rates, expanding hospital networks, and increasing awareness of neonatal jaundice screening.

Get Customization in the report as per your requirements: https://datamintelligence.com/customize/bilirubin-meters-market?kb

Key Segmentations:

• Transcutaneous Segment Leadership: The transcutaneous bilirubinometer segment is projected to lead the global bilirubin meters market, accounting for the highest share of 51.7% due to its non-invasive, rapid, and neonatal-friendly diagnostic advantages.

• By Product Type: Transcutaneous bilirubinometers dominate with over 60% market share, driven by non-invasive neonatal screening demand, while serum bilirubinometers maintain steady adoption in hospital laboratories for confirmatory diagnostics.

• By Age Group: Neonates account for nearly 65%+ of total market share due to high prevalence of neonatal jaundice, whereas adult and geriatric segments are expanding with rising liver disorder and hepatitis cases globally.

• By Indication: Jaundice remains the leading indication with approximately 55% share, supported by routine newborn screening programs, while hepatitis-related bilirubin monitoring is witnessing steady growth in emerging markets.

• By End-User: Hospitals hold the dominant share of around 50-55%, fueled by advanced neonatal care infrastructure, while diagnostic centers are gaining momentum with increasing outpatient bilirubin testing demand.

Market Growth Drivers

✅ Rising Neonatal Jaundice Cases: Over 1.1 million newborns develop severe jaundice annually, with high incidence in South Asia and sub-Saharan Africa, driving urgent demand for early bilirubin screening to prevent complications like kernicterus.

✅ Advancements in Non-Invasive Technology: Modern transcutaneous bilirubin meters leverage light-based detection, AI integration, wireless connectivity, and portable designs to enable faster, painless, and cost-efficient diagnostics.

✅ Growing Healthcare Investments & Awareness: Expanding neonatal care funding, rising hepatitis-related hospitalizations, and increased adoption of point-of-care testing are accelerating market penetration across both pediatric and adult segments.

✅ Aging Population & Liver Disease Burden: Increasing geriatric demographics and chronic liver conditions, particularly hepatitis-related disorders, are fueling sustained demand for bilirubin monitoring in adult healthcare settings.

Contact Us For Custom Research: https://www.datamintelligence.com/custom-research?kb

Empower your strategy with real-time competitor intelligence, forward-looking forecasts, and comprehensive global investment insights all in one place.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?kb

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.